Flash Finance

GPT Healthcare LimitedGPTHEALTHCorporate

Healthcare Latest results: Jun 2026 14 quarters of data
Consolidated Standalone
₹140.74
MCap ₹1,155 Cr · P/E 24.1
GPT Healthcare Limited — Stock analysis & AI research GPT Healthcare Limited — Multibagger AI analysis GPT Healthcare Limited — Seasonality — best & worst months GPT Healthcare Limited — Technical setup — score, trend, support & resistance GPT Healthcare Limited — Live exchange announcements
📋 High ROCE Stocks📋 Stocks Cheaper Than Their Industry📋 Stocks With Strong Quarterly Results📋 High Promoter Holding Stocks 🏭 Healthcare sector
AI-assisted data: figures and text on this page are extracted from public quarterly filings with AI assistance, checked automatically and overseen by our editorial team (human in the loop). They may still contain errors or omissions. Verify critical numbers against official company / SEBI / NSE / BSE filings before making any decision. Educational information only, not financial advice.
₹126 Cr
Sales · Jun 2026
+17.8% YoY
₹24 Cr
Operating Profit · Jun 2026
+41.2% YoY
19.0%
OPM % · Jun 2026
+19.5% YoY
₹13 Cr
Net Profit · Jun 2026
+62.5% YoY
₹1.55
EPS · Jun 2026
+64.9% YoY

📝 GPT Healthcare Limited — results explained

Quarter ended June 2026 (Q1 FY27)

GPT Healthcare Limited reported revenue of ₹126 crore for the quarter ended June 2026 (Q1 FY27), up 17.8% from ₹107 crore in the same quarter last year, and flat sequentially over the March 2026 quarter.

Net profit rose 62.5% year-on-year to ₹13 crore, from ₹8 crore. Earnings per share (EPS) came in at ₹1.55.

Operating profit stood at ₹24 crore — an operating margin (OPM) of 19.0%, compared with 15.9% in the year-ago quarter.

Full year and trailing twelve months

For the full year FY26, GPT Healthcare Limited posted revenue of ₹472 crore, a growth of 15.1% over FY25, with a net profit of ₹43 crore (down 21.9% year-on-year).

On a trailing-twelve-month (TTM) basis, revenue stands at ₹491 crore with a net profit of ₹48 crore.

Valuation snapshot

At the current price of ₹140.74, GPTHEALTH has a market capitalisation of ₹1,155 crore and a trailing P/E of about 24.1.

Within the Healthcare industry, it is the 12th-largest of the 22 companies we track by market value.

Shareholding pattern

As of Jun 2026, promoters held 65.57%, foreign institutional investors (FIIs) 3.03%, domestic institutional investors (DIIs) 6.94%, public shareholders 24.46% of GPT Healthcare Limited.

📈 Share price & events

📊 Quarterly trend

₹ crore · OPM % on right axis

🎯 Key metrics

price-linked ratios use the latest close
Valuation
Market Cap ?
₹1,155 Cr
Current Price ?
₹140.7
P/E ?
24.06below ind
Industry P/E ?
34.70
P/B ?
4.29
P/S ?
2.35
P/FCF ?
28.87
Enterprise Value ?
₹1,246 Cr
EV/EBITDA ?
13.69
PEG ?
8.02
Earnings Yield ?
5.1%
Dividend Yield ?
1.76%
Profitability & Returns
Sales (TTM) ?
₹491 Cr
OPM ?
18.5%
Profit after tax (TTM) ?
₹48 Cr
EPS (TTM) ?
₹5.85
ROCE ?
20.0%
ROE ?
17.8%
ROA ?
10.3%
Growth
Sales — latest qtr ?
₹126 Cr
PAT — latest qtr ?
₹13 Cr
YoY qtr sales growth ?
17.8%
YoY qtr profit growth ?
62.5%
Sales growth (3y) ?
9%
Sales growth (5y) ?
14%
Profit growth (3y) ?
3%
Profit growth (5y) ?
15%
Financial Health
Debt ?
₹91 Cr
Debt to Equity ?
0.34
Interest Coverage ?
7.1
Current Ratio ?
N/A
Ownership
Promoter holding ?
65.57%
Change in promoter holding ?
0.00%
Pledged percentage ?
N/A
Market
Return 3 months ?
-7.7%
Return 6 months ?
2.4%

🗓️ Quarterly results (14 quarters · ₹ Cr)

same fiscal quarter as Jun bestweakest per row · for costs (interest, NPAs) low is best
Metric Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026 YoY % QoQ %
Sales 9696108979998105106101107119120126126 +17.8% +0.0%
Operating Profit 2419252123182725211723212324 +41.2% +4.3%
Other Income 21112211221122 +0.0% +0.0%
Interest 32222111122222 +0.0% +0.0%
Depreciation 44445536567777 +16.7% +0.0%
Profit Before Tax 1914191618152419161115131617 +54.5% +6.2%
Net Profit 10101411131018141381191513 +62.5% -13.3%
EPS 1.301.251.691.441.561.212.181.731.570.941.291.141.781.55 +64.9% -12.9%
OPM % 25.0% 19.8% 23.1% 21.7% 23.2% 18.4% 26.1% 23.2% 20.8% 15.9% 19.3% 17.5% 18.3% 19.0% +19.5% +3.8%

📆 Annual results (₹ Cr, FY = Apr–Mar)

Metric FY25 FY26 TTM YoY %
Sales ₹410 Cr ₹472 Cr ₹491 Cr +15.1%
Operating Profit ₹91 Cr ₹84 Cr ₹91 Cr -7.6%
OPM % 22.18% 17.80% 18.53% -19.7%
NPM % 13.43% 9.11% 9.78% -32.2%
Other Income ₹5 Cr ₹6 Cr ₹6 Cr +9.5%
Depreciation ₹19 Cr ₹27 Cr ₹28 Cr +41.5%
Interest ₹3 Cr ₹8 Cr ₹8 Cr +133.9%
EBIT ₹72 Cr ₹57 Cr ₹63 Cr -20.6%
PBT ₹74 Cr ₹55 Cr ₹61 Cr -25.6%
Tax ₹11 Cr — — —
Net Profit ₹55 Cr ₹43 Cr ₹48 Cr -21.9%
EPS ₹6.69 ₹5.15 ₹5.76 -23.0%
Material Cost ₹38 Cr — — —
Employee Cost ₹43 Cr — — —
Extraordinary Items — — — —

🏛️ Balance Sheet (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Equity Capital 80828282 +0.0%
Reserves 85136166187 +12.7%
Borrowings 82313591 +160.0%
Other Liabilities 7996101104 +3.0%
Total Liabilities 327346384465 +21.1%
Fixed Assets 228224228342 +50.0%
CWIP 36461 -97.8%
Investments 13303243 +34.4%
Other Assets 83857879 +1.3%
Total Assets 327346384465 +21.1%

💧 Cash Flow (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Cash from Operating Activity 66696781 +20.9%
Cash from Investing Activity 5-25-33-47 -42.4%
Cash from Financing Activity -73-48-35-31 +11.4%
Net Cash Flow -2-5-02 —
Free Cash Flow 58501840 +122.2%
CFO/OP 103%95%101%112% +10.9%

➗ Ratios (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Debtor Days 21221816 -11.1%
Inventory Days 43364143 +4.9%
Days Payable 161165161170 +5.6%
Cash Conversion Cycle -97-106-102-112 -9.8%
Working Capital Days -18-16-284 +114.3%
ROCE % 25%30%27%20% -25.9%

👥 Shareholding (latest 5 periods)

Metric Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026 % Chg
Promoters 65.57%65.57%65.57%65.57%65.57% +0.0%
FIIs 4.96%3.20%2.73%2.81%3.03% +7.8%
DIIs 9.33%6.45%6.20%6.84%6.94% +1.5%
Public 20.14%24.77%25.48%24.79%24.46% -1.3%
No. of Shareholders 67,06067,61766,62664,07562,454 -2.5%

⚖️ Peer comparison

Industry: Healthcare · 22 companies · full page →
# Company CMP MCap (Cr) P/E Sales TTM NP TTM OPM% NPM% Sales YoY% NP YoY% Qtr Rev Δ% Qtr NP Δ%
1 VIJAYA Vijaya Diagnostic ₹1,507.80 15,530 82.7 857 187 42.3% 21.8% 19.5% 20.2% 22.8% 37.3%
2 METROPOLIS Metropolis Healthcare ₹596.30 12,370 61.1 1,710 203 24.7% 11.9% 23.6% 31.4% 16.6% 25.7%
3 HCG Healthcare Global ₹704.05 10,512 390.9 2,626 33 18.2% 1.3% 14.6% -53.3% 13.1% 175.3%
4 YATHARTH Yatharth Hospital ₹988.90 9,528 54.1 1,200 171 23.6% 14.3% 36.2% 31.6% 47.6% 16.2%
5 JLHL Jupiter Life ₹277.85 9,109 9.7 1,557 187 22.1% 12.0% 20.9% -6.7% 18.2% -14.5%
6 THYROCARE Thyrocare Technologies ₹555.45 8,841 50.0 876 176 32.1% 20.1% 20.8% 79.4% 24.3% 33.2%
7 KOVAI Kovai Medical ₹6,260.50 6,850 26.7 1,644 256 27.9% 15.6% 15.7% 16.7% 15.3% 20.6%
8 INDRAMEDCO Indraprastha Medical ₹363.20 3,330 17.7 1,524 188 18.0% 12.4% 9.3% 13.7% 11.3% 9.5%
9 KRSNAA Krsnaa Diagnostics ₹543.40 1,763 18.1 816 98 26.8% 12.0% 7.8% 31.0% 22.1% -19.3%
10 SURAKSHA Suraksha Diagnostic ₹311.85 1,624 45.3 325 35 31.4% 10.8% 23.1% 1.4% 20.7% 40.0%
11 SHALBY Shalby ₹132.15 1,418 38.0 1,176 37 12.1% 3.2% 5.0% 1683.0% 11.7% 36.7%
12 GPTHEALTH GPT Healthcare ₹157.90 1,296 27.4 491 48 18.5% 9.8% 15.1% -21.9% 17.8% 62.5%
13 LAXMIDENTL Laxmi Dental ₹196.21 1,080 35.0 287 31 16.2% 10.9% 16.0% -10.1% 13.2% 28.9%
14 NEPHROCARE Nephro Care ₹234.80 387 — — — — — — — 68.4% 347.7%
15 LOTUSEYE Lotus Eye ₹114.50 243 n/m 57 0 8.5% 0.3% 8.4% -89.1% 26.2% 13.0%
16 UNIHEALTH Unihealth Hospitals ₹121.00 190 6.5 132 46 40.9% 34.8% — — 104.6% 71.5%
17 MADHAVBAUG Vaidya Sane ₹148.00 156 19.1 147 8 11.4% 5.6% — — 116.1% 94.3%
18 MHHL Mohini Health ₹57.05 104 — 145 -17 -1.4% -11.7% — — -6.6% -1400.0%
19 MAITREYA Maitreya Medicare ₹120.65 82 — 45 -2 -1.0% -5.5% — — -5.2% -1720.0%
20 AATMAJ Aatmaj Healthcare ₹26.75 60 83.6 24 1 9.7% 2.9% — — 22.5% -39.4%
21 NIDAN Nidan Laborator. ₹33.00 46 30.6 26 2 19.0% 5.9% — — -11.2% -92.0%
22 ARTEMISMED Artemis Medicare ₹315.00 — 48.0 1,081 103 17.4% 9.6% 15.4% 25.9% 16.3% 30.9%
❓ Frequently asked questions
What was GPT Healthcare Limited's revenue in Q1 FY27?
GPT Healthcare Limited reported revenue of ₹126 crore for the quarter ended June 2026 (Q1 FY27), up 17.8% from ₹107 crore in the same quarter last year, and flat sequentially over the March 2026 quarter.
What was GPT Healthcare Limited's net profit in Q1 FY27?
Net profit rose 62.5% year-on-year to ₹13 crore, from ₹8 crore. Earnings per share (EPS) came in at ₹1.55.
What is GPTHEALTH's market capitalisation and P/E ratio?
At the current price of ₹140.74, GPTHEALTH has a market capitalisation of ₹1,155 crore and a trailing P/E of about 24.1.
Who owns GPT Healthcare Limited? (shareholding pattern)
As of Jun 2026, promoters held 65.57%, foreign institutional investors (FIIs) 3.03%, domestic institutional investors (DIIs) 6.94%, public shareholders 24.46% of GPT Healthcare Limited.
TTM ends 2026-06-30. Amounts are ₹ crore unless stated otherwise. Figures are extracted by AI from public quarterly filings; gaps are filled from public market data. Live price refreshed about twice a day from exchange data. Educational information only — not financial advice.
⚠️ How this site is made: Market data pages are computed automatically from NSE/BSE publications and company filings; news articles and announcement analyses are written with AI assistance, with a human in the loop: our editors review what the AI produces. Both can contain errors. Verify with the original sources before any investment decision. Not investment advice; Flash Finance is not SEBI-registered. How we use AI